Molecular mechanisms of lymphangiogenesis in health and disease

Cancer Cell

Volumn 1, Issue 3, 2002, Pages 219-227

  Alitalo, Kari ^a   Carmeliet, Peter ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR 3;

BLOOD VESSEL; CANCER CELL; EMBRYO DEVELOPMENT; GENE THERAPY; HEALTH; HUMAN; KAPOSI SARCOMA; LYMPH FLOW; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHANGIOMA; LYMPHEDEMA; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; GROWTH, DEVELOPMENT AND AGING; LYMPH NODE; LYMPHATIC SYSTEM; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPH NODES; LYMPHATIC SYSTEM; LYMPHEDEMA; NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0036527585     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00051-X     Document Type: Review

References (73)

1. Achen, M.G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A.F., Alitalo, K., and Stacker, S.A. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95, 548-553.
2. Achen, M.G., Williams, R.A., Minekus, M.P., Thornton, G.E., Stenvers, K., Rogers, P.A., Lederman, F., Roufail, S., and Stacker, S.A. (2001). Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J. Pathol. 193, 147-154.
3. Asellius, G. (1627). Asellii Cremonensis Antomici Ticiensis Qua Sententiae Anatomicae multae, nel perperam receptae illustrantur, De Lacteibus sive lacteis venis Quarto Vasorum Mesaroicum genere novo invente Gasp (Milan: Mediolani).
4. Ayadi, A., Zheng, H., Sobieszczuk, P., Buchwalter, G., Moerman, P., Alitalo, K., and Wasylyk, B. (2001). Net-targeted mutant mice develop a vascular phenotypeand up-regulate egr-1. EMBO J. 20, 5139-5152.
5. Banerji, S., Ni, J., Wang, S.X., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D.G. (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801.
6. Birner, P., Schindl, M., Obermair, A., Plank, C., Breitenecker, G., Kowalski, H., and Oberhuber, G. (2000). Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res. 20, 2981-2985.
7. Birner, P., Schindl, M., Obermair, A., Breitenecker, G., Kowalski, H., and Oberhuber, G. (2001). Lymphatic microvessel density as a novel prognostic factor in early- stage invasive cervical cancer. Int. J. Cancer 95, 29-33.
8. Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., Diem, K., Weninger, W., Tschachler, E., Alitalo, K., and Kerjaschki, D. (1999). Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154, 385-394.
9. Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.H., Claesson-Welsh, L., and Alitalo, K. (1998). Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95, 14389-14394.
10. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
11. Carmeliet, P., and Jain, R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257.
12. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583.
13. Carreira, C.M., Nasser, S.M., di Tomaso, E., Padera, T.P., Boucher, Y., Tomarev, S.I., and Jain, R.K. (2001). LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61, 8079-8084.
14. Chang, Y.S., di Tomaso, E., McDonald, D.M., Jones, R., Jain, R.K., and Munn, L.L. (2000). Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl. Acad. Sci. USA 97, 14608-14613.
15. Clark, E., and Clark, E. (1932). Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear. Am. J. Anat. 57, 43-87.
16. Dumont, D.J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., and Alitalo, K. (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949.
17. Dvorak, H.F. (2000). VPF/VEGF and the angiogenic response. Semin. Perinatol. 24, 75-78.
18. Enholm, B., Karpanen, T., Jeltsch, M., Kubo, H., Stenback, F., Prevo, R., Jackson, D.G., Yla-Herttuala, S., and Alitalo, K. (2001). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88, 623-629.
19. Fang, J., Dagenais, S.L., Erickson, R.P., Arlt, M.F., Glynn, M.W., Gorski, J.L., Seaver, L.H., and Glover, T.W. (2000). Mutations in FOXC2 (MFH-1), a fork-head family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67, 1382-1388.
20. Ferrara, N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280, C1358-C1366.
21. Ferrell, R.E., Levinson, K.L., Esman, J.H., Kimak, M.A., Lawrence, E.C., Barmada, M.M., and Finegold, D.N. (1998). Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 7, 2073-2078.
22. Gerli, R., Solito, R., Weber, E., and Agliano, M. (2000). Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 33, 148-157.
23. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
24. He, Y., Kozaki, K., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., and Alitalo, K. (2002). Suppression of tumor lymphangiogenesis, and lymph node metastasis by blocking VEGFR-3 signalling., J. Natl. Cancer. Inst., in press.
25. Huang, X.Z., Wu, J.F., Ferrando, R., Lee, J.H., Wang, Y.L., Farese, R.V., Jr., and Sheppard, D. (2000). Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20, 5208-5215.
26. Huntington, G.S., and McLure, C.F.W. (1908). The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Am. J. Anat. 2, 1-19.
27. Jackson, D.G., Prevo, R., Clasper, S., and Banerji, S. (2001). LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22, 317-321.
28. Jain, R.K., and Fenton, B.T. (2002). Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J. Natl. Cancer Inst. 94, 417-421.
29. Jain, R.K., and Carmeliet, P.F. (2001). Vessels of death or life. Sci. Am. 285, 38-45.
30. Jain, R.K., Munn, L.L., and Fukumura, D. (2002). Dissecting tumors using intravital microscopy. Nat. Rev. Cancer, in press.
31. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R.K., and Alitalo, K. (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.
32. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 1751.
33. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., and Alitalo, K. (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898-3911.
34. Jussila, L., Valtola, R., Partanen, T.A., Salven, P., Heikkila, P., Matikainen, M.T., Renkonen, R., Kaipainen, A., Detmar, M., Tschachler, E., et al. (1998). Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58, 1599-1604.
35. Kadambi, A., Carreira, C.M., Yun, C.O., Padera, T.P., Dolmans, D.E., Carmeliet, P., Fukumura, D., and Jain, R.K. (2001). Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF- receptor 2 and host VEGF-A. Cancer Res. 61, 2404-2408.
36. Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V.W., Fang, G.H., Dumont, D., Breitman, M., and Alitalo, K. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566-3570.
37. Karkkainen, M.J., and Petrova, T.V. (2000). Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19, 5598-5605.
38. Karkkainen, M.J., Ferrell, R.E., Lawrence, E.C., Kimak, M.A., Levinson, K.L., McTigue, M.A., Alitalo, K., and Finegold, D.N. (2000). Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 25, 153-159.
39. Karkkainen, M.J., Saaristo, A., Jussila, L., Karila, K.A., Lawrence, E.C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M.I., et al. (2001). A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 98, 12677-12682.
40. Karpanen, T., and Alitalo, K. (2001). Lymphatic vessels as targets of tumor therapy? J. Exp. Med. 194, F37-42.
41. Karpanen, T., Egeblad, M., Karkkainen, M.J., Kubo, H., Yla-Herttuala, S., Jaattela, M., and Alitalo, K. (2001). Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61, 1786-1790.
42. Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M., Shimizu, K., Awane, M., Sakai, Y., Takabayashi, A., Alitalo, K., et al. (2000). Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96, 546-553.
43. Kubo, H., Cao, R., Brakenhielm, E., Cao, Y., and Alitalo, K. (2002). Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2 induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. USA, in press.
44. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., and Alitalo, K. (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
45. Leak, L.V. (1976). The structure of lymphatic capillaries in lymph formation. Fed. Proc. 35, 1863-1871.
46. Makinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M.I., Pulkkanen, K.J., Kauppinen, R., Jackson, D.G., Kubo, H., Nishikawa, S., et al. (2001a). Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7, 199-205.
47. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E.C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D., et al. (2001b). Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762-4773.
48. Mandriota, S.J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D.G., et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672-682.
49. Marconcini, L., Marchio, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F., and Oliviero, S. (1999). c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96, 9671-9676.
50. Mattila, M.M-T., Ruohola, J.K., Karpanen, T., Jackson, D.G., Alitalo, K. and Härkönen, P.L. (2002). VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer 98, 946-951.
51. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
52. Oden, B. (1960). A micro-lymphangiographic study of experimental wounds by second intention. Acta Chir. Scand. 120, 100-114.
53. Oh, S.J., Jeltsch, M.M., Birkenhäger, R., McCarthy, J.E.G., Weich, H.A., Christ, B., Alitalo, K., and Wilting, J. (1997). VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188, 96-109.
54. Orlandini, M., and Oliviero, S. (2001). In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 276, 6576-6581.
55. Orlandini, M., Marconcini, L., Ferruzzi, R., and Oliviero, S. (1996). Identification of a c-fos-induced gene that is related to the platelet- derived growth factor/vascular endothelial growth factor family. Proc. Natl. Acad. Sci. USA 93, 11675-11680.
56. Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T., and Alitalo, K. (2000). Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156, 1499-1504.
57. Partanen, T.A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S.A., Achen, M.G., and Alitalo, K. (2000). VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 14, 2087-2096.
58. Pepper, M.S. (2001). Lymphangiogenesis and tumor metastasis: myth or reality? Clin. Cancer Res. 7, 462-468.
59. Sabin, F.R. (1902). On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1.
60. Salven, P., Lymboussaki, A., Heikkila, P., Jaaskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., and Joensuu, H. (1998). Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol. 153, 103-108.
61. Schneider, M., Othman-Hassan, K., Christ, B., and Wilting, J. (1999). Lymphangioblasts in the avian wing bud. Dev. Dyn. 276, 311-319.
62. Skobe, M., Brown, L.F., Tognazzi, K., Ganju, R.K., Dezube, B.J., Alitalo, K., and Detmar, M. (1999). Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J. Invest. Dermatol. 113, 1047-1053.
63. Skobe, M., Hawighorst, T., Jackson, D.G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192-198.
64. Stacker, S.A., Caesar, C., Baldwin, M.E., Thornton, G.E., Williams, R.A., Prevo, R., Jackson, D.G., Nishikawa, S., Kubo, H., and Achen, M.G. (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7, 186-191.
65. Stohrer, M., Boucher, Y., Stangassinger, M., and Jain, R.K. (2000). Oncotic pressure in solid tumors is elevated. Cancer Res. 60, 4251-4255.
66. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., and Alitalo, K. (1999). VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 154, 1381-1390.
67. Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T.V., Kubo, H., Thurston, G., McDonald, D.M., Achen, M.G., et al. (2001). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20, 1223-1231.
68. Wang, J.F., Zhang, X.F., and Groopman, J.E. (2001). Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276, 41950-41957.
69. Weninger, W., Partanen, T.A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Rammer, J., Sturzl, M., Kerjaschki, D., Alitalo, K., and Tschachler, E. (1999). Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79, 243-251.
70. Wigle, J.T., and Oliver, G. (1999). Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778.
71. Witte, M.H., Erickson, R., Bernas, M., Andrade, M., Reiser, F., Conlon, W., Hoyme, H.E., and Witte, C.L. (1998). Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31, 145-155.
72. Witte, M.H., Way, D.L., Witte, C.L., and Bernas, M. (1997). Lymphangiogenesis: Mechanisms, significance and clinical implications. In Regulation of angiogenesis, I.D. Goldberg, and E. M. Rosen, eds. (Basel, BirkhäuserVerlag,), pp. 65-112.
73. Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.S., and Isner, J.M. (1998). Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153, 381-394.